BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 28612435)

  • 1. Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee.
    Vidal G; Bursac Z; Miranda-Carboni G; White-Means S; Starlard-Davenport A
    Cancer Med; 2017 Jul; 6(7):1776-1786. PubMed ID: 28612435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
    Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
    J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast Cancer Mortality in African-American and Non-Hispanic White Women by Molecular Subtype and Stage at Diagnosis: A Population-Based Study.
    Tao L; Gomez SL; Keegan TH; Kurian AW; Clarke CA
    Cancer Epidemiol Biomarkers Prev; 2015 Jul; 24(7):1039-45. PubMed ID: 25969506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of clinical, societal, and treatment variables on racial differences in ER-/PR- breast cancer survival.
    Roseland ME; Schwartz K; Ruterbusch JJ; Lamerato L; Krajenta R; Booza J; Simon MS
    Breast Cancer Res Treat; 2017 Aug; 165(1):163-168. PubMed ID: 28547656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding Disparities in Breast Cancer Care in Memphis, Tennessee.
    Lamb EP; Pritchard FE; Nouer SS; Tolley EA; Boyd BS; Davidson JT; Munene G; Fleming MD
    Am Surg; 2018 May; 84(5):620-627. PubMed ID: 29966559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
    Chen L; Li CI
    Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics.
    Nahleh Z; Otoukesh S; Mirshahidi HR; Nguyen AL; Nagaraj G; Botrus G; Badri N; Diab N; Alvarado A; Sanchez LA; Dwivedi AK
    Cancer Med; 2018 Jun; 7(6):2710-2717. PubMed ID: 29733543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Race and ethnicity and breast cancer outcomes in an underinsured population.
    Komenaka IK; Martinez ME; Pennington RE; Hsu CH; Clare SE; Thompson PA; Murphy C; Zork NM; Goulet RJ
    J Natl Cancer Inst; 2010 Aug; 102(15):1178-87. PubMed ID: 20574040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
    Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
    BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of African-American compared to White-American patients with early-stage breast cancer, stratified by phenotype.
    Lehrberg A; Davis MB; Baidoun F; Petersen L; Susick L; Jenkins B; Chen Y; Ivanics T; Rakitin I; Bensenhaver J; Proctor E; Nathanson SD; Newman LA
    Breast J; 2021 Jul; 27(7):573-580. PubMed ID: 33738890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Racial differences in outcomes of triple-negative breast cancer.
    Pacheco JM; Gao F; Bumb C; Ellis MJ; Ma CX
    Breast Cancer Res Treat; 2013 Feb; 138(1):281-9. PubMed ID: 23400579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparities in individual breast cancer outcomes by hormone-receptor subtype, area-level socio-economic status and healthcare resources.
    Akinyemiju T; Moore JX; Ojesina AI; Waterbor JW; Altekruse SF
    Breast Cancer Res Treat; 2016 Jun; 157(3):575-86. PubMed ID: 27255533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Social Determinants and Tumor Biology With Racial Disparity in Survival From Early-Stage, Hormone-Dependent Breast Cancer.
    Hoskins KF; Calip GS; Huang HC; Ibraheem A; Danciu OC; Rauscher GH
    JAMA Oncol; 2023 Apr; 9(4):536-545. PubMed ID: 36795405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
    Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
    Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Racial Disparities in Triple Negative Breast Cancer: A Review of the Role of Biologic and Non-biologic Factors.
    Prakash O; Hossain F; Danos D; Lassak A; Scribner R; Miele L
    Front Public Health; 2020; 8():576964. PubMed ID: 33415093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Racial/Ethnic Differences in Treatment and Mortality Among Women With Triple-Negative Breast Cancer.
    Cho B; Han Y; Lian M; Colditz GA; Weber JD; Ma C; Liu Y
    JAMA Oncol; 2021 Jul; 7(7):1016-1023. PubMed ID: 33983438
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Racial disparities in all-cause mortality among younger commercially insured women with incident metastatic breast cancer.
    Leopold C; Wagner AK; Zhang F; Lu CY; Earle C; Nekhlyudov L; Ross-Degnan D; Wharam JF
    Breast Cancer Res Treat; 2016 Jul; 158(2):333-40. PubMed ID: 27342456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of molecular subtype and race on HR+, HER2- breast cancer survival.
    Reid S; Haddad D; Tezak A; Weidner A; Wang X; Mautz B; Moore J; Cadiz S; Zhu Y; Zheng W; Mayer IA; Shu XO; Pal T
    Breast Cancer Res Treat; 2021 Oct; 189(3):845-852. PubMed ID: 34331630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial disparities in survival outcomes among breast cancer patients by molecular subtypes.
    Zhao F; Copley B; Niu Q; Liu F; Johnson JA; Sutton T; Khramtsova G; Sveen E; Yoshimatsu TF; Zheng Y; Ibraheem A; Jaskowiak N; Nanda R; Fleming GF; Olopade OI; Huo D
    Breast Cancer Res Treat; 2021 Feb; 185(3):841-849. PubMed ID: 33111220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.